retatrutide phase 3 2025 triple agonist glp-1 gip glucagon ππ₯ Retatrutide: The Most Powerful Weight-Loss Drug Yet? π§¬π New clinical results are turning heads retatrutide, a next-generation triple- targeting GLP-1, and receptors, is showing unmatched levels of PDB-101: Molecule of the Month:
Pay in 4 interest-free payments of $7.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Jul 31 - Aug 5


























